By proceeding, you agree to our
27-28 February 2023
The Fierce Drug Safety Summit brings thought leaders from across pharma, biotech, and device companies to explore current challenges faced when ensuring the safety of patients.
28-29 March 2023
These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting financial toxicity, unprecedented politicization of science and eroding public trust.
16-17 January 2023
SAE is proud to present the 11th Annual Pharmaceutical Microbiology UK Conference in January 2023. Microbiology is an essential tool for the detection of microorganisms present in biopharmaceutical and drug product manufacture.
23-24 January 2023
SAE’s 2nd annual Transdermal and Microneedle Drug Delivery conference will explore advances in microneedle diagnostics through case studies and real-world examples, whilst engaging in modern strategies for topical and transdermal drug delivery.
21-23 February 2023
Returning for the 2nd year, the GPCR-Targeted Drug Discovery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs, established large pharma, and key academic opinion leaders committed to dis
31 January-02 February 2023
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.
22-24 February 2023
The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market.
25-27 April 2023
As ADCs as a modality see continued clinical progress, drug developers are becoming more creative with their drug design and new analytical technologies are improving the resolution so that you can understand the characteristics of your drug.
25-26 April 2023
The World Oncology Cell Therapy Congress is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementati
24-26 January 2023
Welcome to the 2nd HFpEF & HCM Drug Discovery & Development Summit The Industry's Only Definitive Forum for Cardiovascular Drug Discovery & Development Cardiovascular stakeholders are racing to answer the burning questions limiting them from capitali